Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tazaki

Showing results (231-240 of 260) with videos related to

Pageof 26
Sort By:
The Japanese Journal of Antibiotics|November 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). II. Background of patients]Y Kumamoto, T Hirose, N Tanaka, et al.
The Japanese Journal of Antibiotics|November 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution]Y Kumamoto, T Hirose, N Tanaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study]Y Aso, H Akaza, K Koiso, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1990
[Percutaneous removal of renal and upper ureteral stones: clinical results and complications of 103 cases]S Shishido, S Baba, T Ohigashi, et al.
The Japanese Journal of Antibiotics|April 1, 1984
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution]N Kosakai, J Igari, Y Kumamoto, et al.
The Japanese Journal of Antibiotics|August 1, 1985
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). I. Susceptibility distribution]N Kosakai, J Igari, Y Kumamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1987
[Cyclophosphamide, adriamycin and cisplatinum combination chemotherapy for advanced urothelial and prostatic carcinoma]T Tsukamoto, H Tanoguchi, M Nakazono, et al.
The Japanese Journal of Antibiotics|October 1, 1989
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution]N Kosakai, Y Kumamoto, T Hirose, et al.
The Japanese Journal of Antibiotics|October 1, 1989
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). III. Secular changes in susceptibility]N Kosaki, Y Kumamoto, T Hirose, et al.
Biochemistry and Molecular Biology International|August 1, 1994
Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cellsX H Wang, C A Whyzmuzis, S An, et al.
Pageof 26

Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
The Japanese Journal of Antibiotics|November 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). II. Background of patients]Y Kumamoto, T Hirose, N Tanaka, et al.
The Japanese Journal of Antibiotics|November 1, 1995
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution]Y Kumamoto, T Hirose, N Tanaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study]Y Aso, H Akaza, K Koiso, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1990
[Percutaneous removal of renal and upper ureteral stones: clinical results and complications of 103 cases]S Shishido, S Baba, T Ohigashi, et al.
The Japanese Journal of Antibiotics|April 1, 1984
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution]N Kosakai, J Igari, Y Kumamoto, et al.
The Japanese Journal of Antibiotics|August 1, 1985
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). I. Susceptibility distribution]N Kosakai, J Igari, Y Kumamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1987
[Cyclophosphamide, adriamycin and cisplatinum combination chemotherapy for advanced urothelial and prostatic carcinoma]T Tsukamoto, H Tanoguchi, M Nakazono, et al.
The Japanese Journal of Antibiotics|October 1, 1989
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution]N Kosakai, Y Kumamoto, T Hirose, et al.
The Japanese Journal of Antibiotics|October 1, 1989
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). III. Secular changes in susceptibility]N Kosaki, Y Kumamoto, T Hirose, et al.
Biochemistry and Molecular Biology International|August 1, 1994
Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cellsX H Wang, C A Whyzmuzis, S An, et al.
Pageof 26